Assignment NURS 6630 Therapy for Patients With Schizophrenia
Assignment NURS 6630 Therapy for Patients With Schizophrenia
According to the Schizophrenia and Related Disorders Alliance of America, approximately 3.5 million
people in the United States are diagnosed with schizophrenia (n.d.), and it is one of the leading causes of
disability. In practice, patients may present with delusions, hallucinations, disorganized thinking,
disorganized or abnormal motor behavior, as well as other negative symptoms that can be disabling for
these individuals. Not only are these symptoms one of the most challenging symptom clusters you will
encounter, many are associated with other disorders, such as depression, bipolar disorder, and
disorders on the schizophrenia spectrum. As a psychiatric nurse practitioner, you must understand the
underlying neurobiology of these symptoms to select appropriate therapies and improve outcomes for
patients. Assignment NURS 6630 Therapy for Patients With Schizophrenia
This week, as you examine antipsychotic therapies, you explore the assessment and treatment of
patients with psychosis and schizophrenia. You also consider ethical and legal implications of these
therapies.
Reference:
Schizophrenia and Related Disorders Alliance of America. (n.d.). About schizophrenia.https://sardaa.org/resources/about-
schizophrenia/#:~:text=Quick%20Facts%20About%20Schizophrenia.%20Schizophrenia%20can%20be%20found,is%20one%20of%20the%20leading%20causes%20of%20disability
Learning Objective
ia
Students wil
Assess client factors and history to develop personalized therapy plans for patients with
insomnia
Analyze factors that influence pharmacokinetic and pharmacodynamic processes in patients
requiring therapy for insomnia
Assess patient factors and history to develop personalized plans of antipsychotic therapy for
patients
Analyze factors that influence pharmacokinetic and pharmacodynamic processes in patients
requiring antipsychotic therapy
Synthesize knowledge of providing care to patients presenting for antipsychotic therapy
Analyze ethical and legal implications related to prescribing antipsychotic therapy to patients
across the lifespan
ORDER A PLAGIARISM-FREE PAPER NOW
Learning Resources
Required Readings (click to expand/reduce)
Medication Resources (click to expand/reduce) Assignment NURS 6630 Therapy for Patients With Schizophrenia
U.S. Food & Drug Administration. (n.d.). Drugs@FDA: FDA-approved drugs.
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm
Note: To access the following medications, use the Drugs@FDA resource. Type the name of each
medication in the keyword search bar. Select the hyperlink related to the medication name you
searched. Review the supplements provided and select the package label resource file associated with
the medication you searched. If a label is not available, you may need to conduct a general search
outside of this resource provided. Be sure to review the label information for each medication as this
information will be helpful for your review in preparation for your Assignments.
amisulpride
aripiprazole
asenapine
brexpiprazole
cariprazine
chlorpromazine
clozapine
flupenthixol
fluphenazine
haloperidol
iloperidone
loxapine
lumateperone
lurasidone
olanzapine
paliperidone
perphenazine
pimavanserin
quetiapine
risperidone
sulpiride
thioridazine
thiothixene
trifluoperazine
ziprasidone
Required Media (click to expand/reduce)
Case study: Pakistani woman with delusional thought processes
Note: This case study will serve as the foundation for this week’s Assignment.
Optional Resources (click to expand/reduce)
Chakos, M., Patel, J. K., Rosenheck, R., Glick, I. D., Hammer, M. B., Tapp, A., Miller, A. L., & Miller, D. D.
(2011). Concomitant psychotropic medication use during treatment of schizophrenia patients:
Longitudinal results from the CATIE study. Clinical Schizophrenia & Related Psychoses, 5(3), 124–134.
https://doi.org/10.3371/CSRP.5.3.2
Fangfang, S., Stock, E. M., Copeland, L. A., Zeber, J. E., Ahmedani, B. K., & Morissette, S. B. (2014).
Polypharmacy with antipsychotic drugs in patients with schizophrenia: Trends in multiple health care
systems. American Journal of Health-System Pharmacy, 71(9), 728–738.
https://doi.org/10.2146/ajhp130471
Lin, L. A., Rosenheck, R., Sugar, C., & Zbrozek, A. (2015). Comparing antipsychotic treatments for
schizophrenia: A health state approach. The Psychiatric Quarterly, 86(1), 107–121.
https://doi.org/10.1007/s11126-014-9326-2. Assignment NURS 6630 Therapy for Patients With Schizophrenia
